Most Type 2 Diabetics Don't Know Disease Cause
WebMD News Archive
"These findings are alarming and demonstrate the critical need for
greater education about insulin resistance to help patients keep their diabetes
in check," said Christine Tobin, president of AADE, in a prepared
statement. "If we can help patients understand the need to directly treat
insulin resistance and take appropriate medications early in the disease, we
will likely improve their overall diabetes management." The AADE study was
funded by SmithKline Beecham Pharmaceuticals, maker of Avandia (rosiglitazone),
a drug designed to treat insulin resistance.
Among the medications for treating insulin resistance is a new class of
drugs called thiazolidinediones (TZD), or "insulin sensitizers."
Instead of trying to make the body produce more insulin, TZDs help make the
body more sensitive and responsive to the insulin already available. The AADE
study noted that only 13% of patients taking oral medications were using TZDs.
Those surveyed who understood insulin resistance were also more likely to be
taking these new drugs.
Bakris says type 2 diabetes should not think taking medication alone will
solve their illness. He says since most patients are overweight, it's also
important to exercise and control their diet. "Patients need to work
closely with their doctors to develop an overall strategy," Bakris tells
WebMD. "And the doctors need to better educate their patients about overall
- A study found nearly 70% of patients with type 2 diabetes had never heard
of insulin resistance, which is a major cause of the disease.
- A new class of drugs, called thiazolidinediones, helps the body become more
sensitive and responsive to insulin that is available, leading to tighter
- Those who have never heard of insulin resistance were less likely to have
good control of their diabetes or be on the newer medications that could